Researchers at the Arc Institute and Stanford University used the Evo model to create synthetic viruses not found in nature. These bacteriophages target bacteria and cannot infect humans or animals. The study demonstrates a precise method for designing biological agents. This capability allows practitioners to engineer specific viral proteins for targeted medical therapies.